ROP

Roche Holding AG

ROP • SW

Fr362.30-Fr3.20 (0.88%)

Estimate

P/E

23.3

EPS

15.56

Beta

0.347

Growth

Revenue, YoY

-1.27%

Net income, YoY

9.8%

FCF, YoY

-9.53%

Forecast

P/E (FWD)

16.5

EPS (FWD)

21.903

Dividends

Dividend yield

2.7%

Annual payout

Fr9.80

Next ex. div date

March 12, 27

Payout

58.76%

Div.rating

About the company

Ticker

ROP

ISIN

CH1499059983

Country

Other

Sector (GICS)

Healthcare

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.

Frequently asked questions

What sector does Roche Holding AG (ROP) operate in?

Roche Holding AG belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Roche Holding AG (ROP) current stock price?

As of the latest data, Roche Holding AG stock price is CHF 362.30, with a previous close of CHF 365.50. Roche Holding AG lost -CHF 3.20 in the last trading session, representing a -0.88% loss.

What is Roche Holding AG (ROP) current market capitalization?

Roche Holding AG market cap is approximately 250.01 billion.

What is Roche Holding AG (ROP) Earnings Per Share (EPS)?

The trailing EPS is CHF 15.56, and the forward EPS is CHF 21.90.

What is Roche Holding AG (ROP) Price-to-Earnings (P/E) ratio?

Roche Holding AG current P/E ratio is 23.28, with a forward P/E of 16.54.

What is Roche Holding AG (ROP) EBITDA?

Roche Holding AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 9.44 billion.

Does Roche Holding AG (ROP) pay dividends?

Yes. Roche Holding AG pays annual dividends with an annualized yield of 2.7% and an estimated annual payout of CHF 9.80 per share.

When is the next ex-dividend date for Roche Holding AG (ROP)?

The next ex-dividend date is scheduled for March 12, 2027.

When is Roche Holding AG (ROP) next earnings report?

Roche Holding AG is expected to release its next earnings report on June 30, 2026.

What is Roche Holding AG (ROP) beta (volatility) score?

Roche Holding AG has a beta of 0.347, indicating lower volatility than the overall market.